Literature DB >> 31685331

Dual mode of binding of anti cancer drug epirubicin to G-quadruplex [d-(TTAGGGT)]4 containing human telomeric DNA sequence induces thermal stabilization.

Shailja Raje1, Kumud Pandav1, Ritu Barthwal2.   

Abstract

Epirubicin exerts its anti cancer action by blocking DNA/RNA synthesis and inhibition of topoisomerase-II enzyme. Recent reports on its influence on telomere maintenance, suggest interaction with G-quadruplex DNA leading to multiple strategies of action. The binding of epirubicin with parallel stranded inter molecular G-quadruplex DNA [d-(TTAGGGT)]4 comprising human telomeric DNA sequence TTAGGG was investigated by absorption, fluorescence, circular dichroism and nuclear magnetic resonance spectroscopy. The epirubicin binds as monomer to G-quadruplex DNA with affinity, Kb1 = 3.8 × 106 M-1 and Kb2 = 2.7 × 106 M-1, at two independent sites externally. The specific interactions induce thermal stabilization of DNA by 13.2-26.3 °C, which is likely to come in the way of telomere association with telomerase enzyme and contribute to epirubicin-induced apoptosis in cancer cell lines. The findings pave the way for drug designing in view of the possibility of altering substituent groups on anthracyclines to enhance efficacy using alternate mechanism of its interaction with G4 DNA, causing interference in telomere maintenance pathway by inducing telomere dysfunction.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Absorption and Fluorescence; Anticancer drug epirubicin; Circular dichroism; Nuclear magnetic resonance; Telomeric G-quadruplex DNA; Thermal denaturation

Mesh:

Substances:

Year:  2019        PMID: 31685331     DOI: 10.1016/j.bmc.2019.115131

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Ursolic Acid Enhances the Sensitivity of MCF-7 and MDA-MB-231 Cells to Epirubicin by Modulating the Autophagy Pathway.

Authors:  Zhennan Wang; Pingping Zhang; Huan Jiang; Bing Sun; Huaizhi Luo; Aiqun Jia
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

2.  The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma.

Authors:  Min Pan; William C Wright; Richard H Chapple; Asif Zubair; Manbir Sandhu; Jake E Batchelder; Brandt C Huddle; Jonathan Low; Kaley B Blankenship; Yingzhe Wang; Brittney Gordon; Payton Archer; Samuel W Brady; Sivaraman Natarajan; Matthew J Posgai; John Schuetz; Darcie Miller; Ravi Kalathur; Siquan Chen; Jon Patrick Connelly; M Madan Babu; Michael A Dyer; Shondra M Pruett-Miller; Burgess B Freeman; Taosheng Chen; Lucy A Godley; Scott C Blanchard; Elizabeth Stewart; John Easton; Paul Geeleher
Journal:  Nat Commun       Date:  2021-11-09       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.